LONDON: Public health body over Africa plans to speak with Merck about obtaining Molnupiravir treatment pills for Covid-19, although talks with Pfizer about paxlovid drugs are more advanced, he said on Thursday.
“We have no preference to speak only with Pfizer and not Merck, only Pfizer is more advanced with their engagement.
We plan to involve the two companies equally,” said John Nkengasong, Director of the Central Disease for Disease Control and Prevention.